Heparan sulphate proteoglycans are rapidly released from VACO IOMS colon cancer cells that are triggered with phorbol esters to undergo terminal differentiation. This lag-free temperature-sensitive process is correlated with a conversion of the lipophilic proteoglycans of the cell surface into non-lipophilic proteoglycans that accumulate in the culture medium. The released proteoglycans are very similar to their lipophilic precursors in size, buoyant density and glycosaminoglycan characteristics; however, they exhibit slightly smaller core proteins after chemical and enzymic deglycosylation. The lipophilicity of the larger-sized core proteins of the cell-associated proteoglycans is also correlated with the presence of an easily iodinatable domain; this domain is missing in the released proteoglycans. Exogenous proteases (i.e. chymotrypsin, V8, trypsin and proteinase K) readily cleave this segment from the larger protease-resistant region of the proteoglycan structure. It is also released intact by treatment of the isolated proteoglycans with methanolic HCl. This component appears to be peptide in character, in that proteases readily degrade it and release iodotyrosines when the precursor has been iodinated. No evidence for the presence of covalently attached fatty acids in the cell-associated proteoglycans was found. These results are consistent with the hypothesis that the altered proteoglycan metabolism that is associated with the phorbol-ester-induced terminal differentiation of certain human colon cancer cells ensues upon the activation of a membrane-localized protease that cleaves a lipophilic anchor segment from the cell surface proteoglycans.
INTRODUCTION
Heparan proteoglycans are abundant in the plasma membranes of actively growing cells [1, 2] . However, the level of this strongly acidic class ofglycoproteins decreases rapidly as cells are tn-ggered to differentiate terminally. For example, erythroleukaemia cells that are forced to differentiate with polar solvents exhibit a striking decrease in surface charge, a response which is partially attributable to the loss of heparan sulphate proteoglycans [3, 4] .
Similarly, PC12 pheochromocytoma cells lose about 70% of their cell surface heparan sulphate to the culture medium as they differentiate in response to nerve growth factor [5] . Finally, our laboratory has shown previously that the differentiation ofcertain human colon cancer cells under the influence of phorbol esters is correlated with a rapid release of cell surface heparan sulphate proteoglycans to the culture medium [6] . This loss of proteoglycans in experimentally differentiated cell systems, along with immunological evidence showing a relative deficiency of these entities in the more differentiated members of epithelial cell lineages in vivo [7] [8] [9] , prompts the hypothesis that heparan sulphate proteoglycan metabolism may play a key role in regulating the balance between cell replication and cell differentiation.
To explore this concept, our laboratory has studied the mechanism underlying the phorbol-ester-induced release of cell surface heparan sulphate proteoglycans from cells of the VOM human colon cancer line [6, 10] . This research has revealed that cell-associated heparan sulphate proteoglycans contain a lipophilic peptide domain that is missing from the proteoglycans that have been released to the medium. Accordingly, it is postulated that proteoglycan release under the influences of the phorbol ester proceeds via protein kinase C activation of a membraneassociated protease that cleaves the lipophilic membrane- anchoring domain from the cell-associated proteoglycan, releasing the heparan sulphate-bearing domain to the culture medium. The potential importance of this process in the control of malignant cell growth is discussed.
MATERIALS AND METHODS Materials
Pronase, Zwittergent 3-14 and CHAPS detergent were from Calbiochem. Triton X-100 (membrane grade), phosphatidylinositol phospholipase C (Bacillus cereus) and proteinase K were from Boehringer Mannheim. PMA was from LC Services, Woburn, MA, U.S.A. CsTFA, octyl-Sepharose CL4B, DEAESephacel and Sepharose CL4B were from Pharmacia. TPCKtreated trypsin was from Cooper Biomedical. V8 protease, Ba(NO2)2 and heparitinase were from ICN Biochemicals. Guanidine hydrochloride dextran sulphate 8000, heparinase and TLCK-treated chymotrypsin were from Sigma. Phenol and sodium thiocyanate were from Mallinckrodt. Trifluoroacetic acid, CPC, CNBr and acetyl chloride were from Aldrich. lodobeads were from Pierce. Aquasure scintillation fluid, Protocol for proteoglycan prelabelling VOM cells were grown in DMEM/2 % FBS containing 5 ,uCi of [35S]sulphate/ml for 16-18 h. Specific radioactivities were 100 mCi/mmol (50 4uM-sulphate; for release assays) or 6 mCi/mmol (800 /sM-sulphate; for isolation and lipophilic fractionation of proteoglycans). Alternatively, cells were cultured in DMEM/2 % FBS with ['4C]glucosamine (10 ,Ci/ml) and 0.2 g of glucose/l. Each labelling regimen included a further 90 min incubation in label-free medium.
Proteoglycan release assay
Prelabelled cells in 10 cm2 wells were fed on medium containing PMA (100 nM) or vehicle [0.025 % (v/v) ethanol]. At the indicated incubation times the medium was removed and clarified by centrifuging at 1000 g for 10 min and then mixed with 100 ,ug of dextran sulphate (Mr 8000; Sigma) as a co-precipitate for the released proteoglycans. The cells were removed from dishes with 0.05% (w/v) trypsin, 0.01 % (w/v) EGTA and 0.01 % (w/v) dextran sulphate in S-MEM (15-30 min at room temperature). An equal volume of a solution containing 0.2% (w/v) CPC, 10 mM-EDTA, 10 mM-sulphate and 10 mM-acetate (pH 6) was added to each of these samples in silicone-treated tubes. Final salt concentrations were less than 100 mM-Nat. After 60 min at 36°C, CPC-proteoglycan precipitates were collected on glass fibre filters (Whatman GF-C) and counted for radioactivity by liquid scintillation in Aquasure fluid.
Proteoglycan isolation 1111
Prelabelled cells were lysed with 1 % (w/v) Zwittergent 3-14, 100 mM-NaCl, 50 mM-Tris/HCl, 10 mM-EDTA, 2 mM-N-ethylmaleimide (NEM), 0.5 mM-phenylmethanesulphonyl fluoride (PMSF) and 100 ,ug of pepstatin A/ml. After 15 min at 4°C, the soluble fraction was collected by centrifugation at 1000 g for 15 min. Detergent-insoluble materials were rinsed once with the same detergent solution, and the combined extracts were used for proteoglycan isolation by density centrifugation.
Solutions were adjusted to contain 5% (w/v) guanidinium chloride, 50 mM-Tris/HCl and 0.8 % Zwittergent 3-14, then extracted with phenol three times (heated to 60°C during the first extraction). This procedure removes non-glycosylated proteins and lipid. The aqueous plus interfacial phases were then extracted with ether to remove phenol and then concentrated to approx.
I vol. by vacuum centrifugation (SpeedVac, Savant Instruments, Hicksville, NY, U.S.A.). Samples were then rediluted to give 4 M-guanidinium chloride, adjusted to pH 7.5, reduced with 10 mM-dithiothreitol for 2 h at 48°C, and alkylated with 25 mM-N-ethylmaleimide.
This solution was adjusted to contain 1 % (v/v) Triton X-100, mixed with an equal volume of CsTFA (density 1.7 g/ml), and the sample was layered over 2 vol. of CsTFA (1.7 g/ml). After centrifugation for 44 h at 45000 rev./min in an SW50.1 rotor operated at 20°C, fractions were collected from the bottom and assayed for density (by weighing 100,1 samples) and radioactivity. Fractions with proteoglycan were concentrated by Centricon 30 centrifugal ultrafiltration (Amicon Corp., Lexington, MA, U.S.A.).
For the density isolation of the cell-released proteoglycans, the culture medium was collected by centrifugation to remove nonadherent cells and debris. It was then precipitated with 0.1 % CPC as described above (except without the dextran sulphate carrier). The CPC-proteoglycan complexes were sedimented at 10000 g for 60 mmn at 20°C, dissolved in 4 M-guanidinumm chloride and then used for density sedimentation as described above for the cell-associated proteoglycans.
Chromatographic separations of proteoglycans
Octyl-Sepharose CL4B in Pasteur pipettes (0.4 cm diameter x 5 cm bed volume) was pre-equilibrated with 4 M-guanidinium chloride in 50 mM-Na-EDTA/50 mM-sodium acetate (pH 6) before receiving the above sample in the same solution. After adsorption had occurred for 1 h, non-adsorbed materials were collected by washing each column with 5 column vol. of the same solution. A linear gradient of 0-1 % Triton X-100 in this solution was then flowed through at 1.5 ml/h for 5 h; 0.5 ml fractions were collected throughout this elution period. Lipophilic proteoglycans are defined as proteoglycans that adsorb to octylSepharose in 4 M-guanidinium chloride and can be subsequently eluted with Triton X-100 at approx. 0.2 % Triton X-100. For this study, non-lipophilic proteoglycans are those which fail to adsorb to this matrix in 4 M-guanidinium chloride.
Lipophilic proteoglycans for structural studies described herein were obtained from the high-density (1.5-1.75 g/ml) regions of the gradient and were further purified by adsorption to octylSepharose and subsequent elution with a Triton X-100 gradient (0-1 %) in 4 M-guanidinium chloride. Proteoglycan-containing fractions were then concentrated by ultrafiltration (Centricon 30), washed twice on the filters with 4M-guanidinium chloride (to remove Triton X-100), and then recovered in CHAPS buffer (20 mM-CHAPS detergent, 100 mM-NaCl, 50 mM-Tris/HCl, pH 7.5 at 20°C). These proteoglycan preparations were stored at this step at -20°C in CHAPS buffer. These purification methods are detailed elsewhere [11] .
Gel filtration of such products on 0. [12] . Incubation was for 18 h at 20 'C.
Chemical degradations
HNO2 was prepared by mixing equal volumes of cold I MBa(NO2)2 and 1 M-H2SO4 and pelleting the resultant BaSO4 at 15 000 g for 5 min [13] . Then 20 ,al of 1 M-HNO2 was mixed with 5 pil of proteoglycan in CHAPS buffer with 20,g of BSA. After 5 min at 20 'C, the HNO2 was removed by evaporation using a high-vacuum centrifuge, and the non-volatile materials were dissolved in 50 ,1 of SDS/PAGE buffer.
Alkaline elimination ofglycosaminoglycans from core proteins was effected by adding 0.2 ml of a mixture of 0.1 M-NaOH and 0.5 M-NaBH4 and incubating at 48 'C for 18 h. After neutralization with 50 % (v/v) acetic acid, H2 was allowed to evolve for 2 h before analysis of the sample by gel filtration.
Methanolic HC1 (0.6 M) was prepared by adding 0.25 ml of acetyl chloride to 5 ml of anhydrous methanol and allowing it to cool for 1 h under N2. Then 50 ,u of this solution was added to freeze-dried proteoglycan. After 18 h of incubation at 20 'C under N2, methanol and HCI were removed by vacuum centrifugation.
Hydroxylamine hydrochloride at 1 M in 33 mM-Tris/HCl buffer, pH 8, was added as 0.1 ml to 10,ul of proteoglycan in CHAPS buffer and incubated at 20 'C for 5 h. gel t.l.c. plates and chromatographed in benzyl alcohol/ acetone/I M-NH3 (1:4: 1, by vol.) [15] . '25l-labelled spots were detected by autoradiography, and standards were located as the yellow photochemical reaction product generated during u.v. irradiation of the t.l.c. plate (1 h at 0.8 m from a 30 W G.E. germicidal light).
RESULTS
Characteristics of the PMA-labile pool of VOM-cell-associated proteoglycans VOM cells rapidly release cell surface proteoglycans in response to a phorbol ester treatment that leads to terminal differentiation [6] . Most of these [35S]sulphate-prelabelled macromolecules can be recovered from the culture medium by precipitation with the cationic amphiphile CPC. This release process is independent of new protein synthesis and is rapidly initiated in the cultured cells without an appreciable lag period ( [14] . Samples were heated to 95°C for 5 min in 1 % SDS/2 % (v/v) 2-mercaptoethanol before electrophoresis. For direct autoradiography of 1251, electrophoresed gels were wrapped in Saran film and placed on X-ray film over an intensifying screen at -80 'C. Fixation and staining were for 60 min in 0.1 % (w/v) Coomassie Blue in 12.5 % (w/v) trichloroacetic acid with 3 % acetic acid, followed by extensive washing in 7 % acetic acid. For 35S autoradiography, fixed gels were impregnated with 5 % (v/v) glycerol in 5 The released proteoglycans appear to be derived from cellsurface-exposed integral membrane proteins. The increase in soluble proteoglycan is correlated with a decrease in that fraction of proteoglycans which are releasable on treatment of the cells with trypsin [6] or pronase at 4°C (Fig. 2a) (Fig. 2b) Sepharose [11] . When the proteoglycan preparations from control VOM cells were applied to this matrix in 4 M-guanidinium chloride, 30-50 % of total label adsorbed to the resin and was eluted with 0.2 % Triton X-100, the critical micelle concentration of this detergent in 4 M-guanidinium chloride. PMA treatment of cells was associated with a progressive depletion of this pool. There was an associated increase, however, in the exclusively (>95 %) non-lipophilic species recoverable from the culture medium (Fig. 3) . This conversion from lipophilic to nonlipophilic state was very rapid; in one experiment, 30 min of PMA treatment decreased the lipophilic proteoglycan fraction to 40% of its starting level. In contrast, the non-lipophilic cellassociated pools {consisting of detergent-soluble and -insoluble glycosaminoglycans, proteoglycans, and a minor (< 5 % of total label) unidentified sulphated macromolecule [1 1]} remain at 80-90 % of their starting levels during 5 h of treatment with PMA or control medium. Thus PMA appears to cause a preferential proteoglycan release from a pre-existing lipophilic pool. Consistent with this interpretation, the guanidiniuminsoluble fraction discussed above was found to be highly enriched in octyl-Sepharose-binding proteoglycans. As a test of the potential for membrane intercalation of the lipophilic proteoglycans, preparations of cell-associated proteoglycan which had been adsorbed to octyl-Sepharose and then eluted with Triton X-100 were mixed with detergent-dispersed dipalmitoyl phosphatidylcholine in the presence of 4 Mguanidinium chloride and dialysed to obtain liposomes. When these preparations were centrifuged, 70 % of lipophilic proteoglycan, but less than 3 % of culture-medium-derived proteoglycans, co-sedimented with the vesicles (Table 1) . Treatment of these preparations with either trypsin or detergent before centrifugation solubilized the liposome-associated proteoglycans, whereas a high-salt solution had no effect. This finding is taken as evidence that these molecules are externally displayed and lipid-anchored. This distinctly different lipophilicity of the PMAreleased proteoglycan and the cell-associated precursor suggests that the latter is structurally altered en route to its release.
As revealed in the high-resolution density profile of these isolated fractions (Fig. 4) , the two proteoglycan classes have very similar densities. Accordingly, one must conclude that the lipophilic determinants ofthe cell-associated proteoglycans either have low mass relative to the glycosaminoglycan-bearing segments or have a similar density to the glycosaminoglycans. These densities (1.65 + 0.10 g/ml) also suggest that the ratio of protein (density 1.2-1.4 g/ml) to glycosaminoglycan (density as high as 2.2 g/ml in CsTFA) in the two products is quite similar, or is simply dominated by the high density of sulphated polysaccharides.
Both classes of proteoglycans migrated through Sepharose CL4B gel-filtration media as very large and polydisperse molecules with similar size distributions (90 % of label at Kav 0.25 +0.20; Fig. 5 ). Upon reductive alkaline-elimination Table 1 . Incorporation of proteoglycans into phosphatidylcholine liposomes Proteoglycans were mixed with dipalmitoyl phosphatidylcholine in 4 M-guanidinium chloride containing CHAPS, and dialysed to produced liposomes as detailed in the Materials and methods section. A portion of each liposome suspension was added to 10 vol. of Tris-buffered saline containing (a) no addition, (b) 100 ,ug of TPCK-treated trypsin/ml, (c) 0.1 % Triton X-100 or (d) 1 M-NaCl. After incubation for 5 h at 36°C, each preparation was centrifuged at 15000 g for 10 min at 4°C to separate soluble from sedimentable materials. Data This latter preparation and the proteoglycan from the culture medium were placed in 50 mM-Tris/HCI/2 M guanidinium chloride/ 2 M-CsTFA/0.5 % Triton X-100 (density 1.4 g/ml) and layered over an equal volume of CsTFA (1.7 g/ml). After 44 h at 35000 rev./min in an SW50.1 rotor, the gradients were fractionated from the bottom and analysed for radioactivity and density. Studies of the proteoglycan core proteins
In attempts to characterize the source of lipophilicity in cellassociated proteoglycans, the proteoglycan preparations from cells and medium respectively were iodinated by using immobilized chloramine-T (lodobeads) and Na125I. Under standard labelling conditions, the lipophilic cell-associated proteoglycans were found to incorporate [5] [6] [7] [8] [9] [10] (Fig. 6, lanes 1 and 2) labelled proteoglycan from the culture medium, lacking the lipophilic domain, failed to be incorporated into liposomes (Table 1) or bind to octyl-Sepharose (results not shown). Core proteins reflecting the two classes of proteoglycans were generated by specific degradation of glycosaminoglycan with either heparanase or HNO2 (Fig. 6) . In each case the deglycosylated 1251-labelled proteoglycan products were decreased in size to Mr 30000-40000 (70-80%) and Mr 110000-150000 (10-30 %). The similarity of the sizes of products resulting from both chemical and enzymic degradation of the two proteoglycan preparations suggests that the two major bands in each are representative of two distinct core proteins rather than artifacts of either deglycosylation treatment (e.g. cross-linking adventitious proteases or acid cleavage). resulted in the production of a M,-18 000 1251-labelled species (Fig. 7) . This latter material appeared to be peptide in that it was chloroform/methanol-insoluble, could be fixed in polyacrylamide gels with 25 % (w/v) trichloroacetic acid, has been efficiently electroblotted on to polyvinylidene difluoride membranes, and was digestible with Pronase. The 1251-labelled products of Pronase digestion co-migrated on silica-gel t.l.c. with authentic iodotyrosines. In contrast with methanolic HCl treatment, only limited amounts of this peptide were generated during treatment of the iodinated lipophilic proteoglycan for 18 h with aqueous solutions of 5 % (v/v) HCI or 75 % (v/v) trifluoroacetic acid, thereby suggesting a requirement for anhydrous conditions for efficient cleavage.
The unique presence of iodinatable peptide structures on the lipophilic proteoglycans is also revealed by protease treatment of the two preparations. As previously shown [11] , the glycosaminoglycan-bearing segment of these molecules is little decreased in size by any of four commonly used proteases, as revealed by the electrophoretic migration of[35S]sulphate-labelled products in polyacrylamide gels (Figs. 8a and 8b) . If 125I-labelled lipophilic proteoglycans are subjected to the same analyses, a series of protease-generated peptides can be shown to account for > 80% of the 125I label (Fig. 9a) . These easily iodinated peptide segments show high affinity for octyl-Sepharose after cleavage from the parent molecules (J. A. McBain, unpublished work). The proteoglycans of the medium (i.e. PMA-released products) retain label as polydispersed high-Mr species after protease treatment (with the notable exception of chymotrypsin) (Fig. 9b) .
DISCUSSION
Work from this laboratory has documented that the initiation of terminal differentiation of the human colon cancer cell VACO-1OMS by phorbol esters and other agents which activate protein kinase C [18] is associated with a rapid release of cell surface proteoglycans of the heparan sulphate type [6] . This PMA response, which is followed by an acceleration of proteoglycan resynthesis, was also observed in other growth-arrest-susceptible cells, including human adenocarcinoma cell lines derived from colon (VACO 1, SW1222 and butyrate-treated VACO Release of cell surface proteoglycans13 [20] [21] [22] [23] , as opposed to the glycosylphosphatidylinositol-anchored types [24, 25] . At the present level of resolution, it is clear that at least one of the two VOM-cell proteoglycan core proteins undergoes proteolytic cleavage en route to its release from the cell. A similar cleavage has been postulated [26, 27] to occur during release of syndecan, which is, like the VOM-cell proteoglycans, absent from terminally differentiated cells [7] [8] [9] . The high degree of interspecies amino acid sequence conservation involving the syndecan intra-and juxta-cellular domains suggests that these molecules may be similarly recognized by cytoplasmic, cytoskeletal and plasma-membrane-associated proteins which are involved in proteoglycan turnover. In VOM cells, neither spent medium of PMA-treated cells nor any of a variety of commercially available protease inhibitors was able to alter the rates of spontaneous or PMA-induced proteoglycan release (J. A. McBain & G. C. Mueller, unpublished work). Accordingly, this release may be initiated by a novel membrane-localized protease [28] that is activated by a protein kinase C-mediated phosphorylation. However, it is also possible that proteoglycan release follows core protein phosphorylation by protein kinase C at specific sites on the cytoplasmic domains. This might facilitate proteoglycan translocation along the plane of the membrane-and complexation with existing active proteases. The extraordinary susceptibility of the lipophilic anchor peptides to mild methanolic-HCI-catalysed cleavage may be an additional clue to the release mechanism. This chemical cleavage may be an N-to-O acyl shift, involving transfer of a peptide chain from the amino to the hydroxyl group of a susceptible serine or threonine by way of a hydroxyoxazolidine intermediate [29] , followed by hydrolysis of the resulting ester. We are, however, unaware of enzymic reaction mechanisms which combine the extraordinary dehydration and proton donation necessary for such a cleavage.
The relationship of an accelerated proteoglycan release to terminal differentiation is unclear at present, but, since heparan sulphate proteoglycans can bind to certain growth factors [30] [31] [32] [33] , cross-link specific sites on extracellular-matrix components, facilitating their assembly [34, 35] , span the membrane to contact the intracellular cytoskeleton [36] , and act as precursors for nuclear targeting sulphated glycosaminoglycans [37] , a variety of effects or roles can be visualized [6] . In particular, the PMAinduced alterations in the cell surface density of proteoglycan might derange the growth-factor responses which determine cell survival. For example, heparan sulphate glycosaminoglycans are essential components of the high-affinity class of fibroblastgrowth-factor receptors [38] [39] [40] and withdrawal of specific heparin-binding growth factors from growing cells for defined periods of time are sufficient to trigger either terminal differentiation [41, 42] or apoptotic cell death [43, 44 ]. An additional possible effect of cell surface proteoglycan release on viability is the hyperpolarization of transmembrane potential (owing to loss of polyanion from one face of the membrane), with attendant effects on cation (e.g. Ca2+)-transport rates.
Thus it appears that altered cell surface proteoglycan metabolism may be generally coupled to processes that regulate the balance between cell replication and terminal growth states. Whatever the mechanism, this cellular response to PMA is of considerable interest in that it is associated with the triggering of terminal differentiation in adenocarcinoma cells. We hope that knowledge of the underlying process will explain how two unique activators of protein kinase C, bryostatin 1 and PMA, exhibit diametrically opposite effects on both cell growth and proteoglycan metabolism in VACO-lOMS [45] and the other differentiation-responsive cells. Most 
